Yahoo · Sep 15, 2026
UnitedHealth Group Announces Earnings Release Date
September 15, 2026--UnitedHealth Group will release its third quarter 2026 financial results on Tuesday, October 13, 2026, before the market opens.
NASDAQ · UNH
UNITEDHEALTH GROUP INCORPORATED (Delaware)
Healthcare · Medical - Healthcare Plans
$375.93
Down-$7.62 (-1.99%)
Updated Sep 16, 2026, 12:27 PM
SID Score
7.0/10
Composite research score
Smart Money
52/100
Neutral
- Market cap
- 305B
- P/E ratio
- 17.38
- Dividend yield
- 2.32%
- 52-week range
- $255.97 – $461.62
- Volume
- 4.39M
- Avg. volume
- 8.77M
Price performance
UNH price history
1M range · 20 trading sessions · Daily adjusted prices
UNH closed at $375.93 after 20 trading sessions, down 4.57% for the selected period.
- Last close
- $375.93
- Period change
- -4.57%
- Period low
- $375.93
- Period high
- $401.01
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $383.55 | $383.80 | $375.50 | $375.93 | 4.39M |
| Sep 14, 2026 | $381.44 | $386.46 | $379.2814 | $383.55 | 4.48M |
| Sep 11, 2026 | $390.42 | $391.73 | $375.90 | $379.09 | 7.48M |
| Sep 10, 2026 | $396.00 | $399.265 | $387.60 | $388.28 | 4.35M |
| Sep 9, 2026 | $405.17 | $406.53 | $378.0801 | $393.06 | 7.74M |
| Sep 8, 2026 | $392.40 | $403.885 | $390.44 | $400.84 | 7.05M |
| Sep 4, 2026 | $397.05 | $402.225 | $395.20 | $397.14 | 5.57M |
| Sep 3, 2026 | $400.02 | $405.16 | $395.3005 | $400.94 | 5.49M |
| Sep 2, 2026 | $399.27 | $401.14 | $396.51 | $399.66 | 3.27M |
| Sep 1, 2026 | $392.08 | $399.60 | $391.78 | $396.30 | 3.72M |
| Aug 31, 2026 | $393.52 | $394.49 | $387.71 | $389.41 | 5.75M |
| Aug 28, 2026 | $396.42 | $396.74 | $392.66 | $392.95 | 2.46M |
| Aug 27, 2026 | $396.87 | $399.88 | $393.77 | $395.05 | 3.67M |
| Aug 26, 2026 | $396.33 | $406.25 | $396.01 | $401.01 | 3.56M |
| Aug 25, 2026 | $397.80 | $399.03 | $395.62 | $396.59 | 2.66M |
| Aug 24, 2026 | $391.04 | $399.58 | $390.855 | $398.76 | 4.69M |
| Aug 21, 2026 | $386.00 | $393.655 | $386.00 | $390.11 | 4.89M |
| Aug 20, 2026 | $388.25 | $392.7095 | $383.83 | $384.85 | 4.5M |
| Aug 19, 2026 | $394.57 | $396.80 | $386.33 | $388.61 | 5.27M |
| Aug 18, 2026 | $397.43 | $398.79 | $393.51 | $393.93 | 3.61M |
Latest UNH news
The latest Smart Investors Daily articles mentioning UNH.
Stock researchCompany · Overview
UNH research
Overview
Company profile and research snapshot.
Company profile
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $387.80
- Implied upside
- —
- Analysts
- 21
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 21, 2026 | Mizuho | Outperform | — |
| Jul 21, 2026 | JP Morgan | Overweight | — |
| Jul 20, 2026 | Barclays | Overweight | — |
| Jul 17, 2026 | RBC Capital | Outperform | — |
| Jul 17, 2026 | UBS | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 15, 2026
How UnitedHealth (UNH) Leads the AI Revolution in the Insurance Industry
Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. Following a strong rebound from the first-quarter decline, the S&P 500 gained 15.2% as accelerating capital spending toward artificial intelligence infrastructure drove significant gains across technology hardware companies. Semiconductor and data-center-related businesses benefited from supply constraints […]
Yahoo · Sep 15, 2026
The Zacks Analyst Blog Highlights United Health, Dell Technologies and The Goldman Sachs
UnitedHealth, Dell and Goldman Sachs headline a week of rate decisions, rising commodity inflation and global political uncertainty.
Yahoo · Sep 15, 2026
Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth
CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.
AI research layers
Interpretive context generated from the platform’s current data sources.
UnitedHealth Group Stock Performance
UnitedHealth Group shares traded at $375.93, reflecting a daily decline of approximately 1.02%, per SID market data. Over the trailing one-month period, UNH posted a loss of 6.42%, while the three-month return stood at negative 8.54%, indicating sustained selling pressure in recent weeks. On a one-year basis, the stock has gained 11.64%, underperforming many large-cap healthcare peers. Technically, UNH trades below its 50-day moving average of $407.49 but remains above its 200-day moving average of $345.84, according to Massive/Polygon data. The 14-day relative strength index registers at 35.0, approaching oversold territory and suggesting downside momentum has been dominant. The stock carries a beta of 0.432, indicating significantly lower volatility relative to the broader market. Average daily trading volume stands at approximately 8.77 million shares, reflecting robust liquidity for institutional participants navigating current price levels.
UnitedHealth Group Valuation Analysis
UnitedHealth Group currently carries a market capitalization of approximately $305 billion, making it one of the largest companies in the healthcare sector, per SID market data. The stock trades at a price-to-earnings ratio of 17.38, which sits below the broader S&P 500 average, reflecting a valuation discount potentially tied to recent share price weakness. The price-to-book ratio stands at 3.19, according to SEC filings, consistent with a capital-light managed care business model. Notably, UNH's PEG ratio is negative at -1.02, driven by downward earnings growth revisions that complicate traditional growth-adjusted valuation frameworks. The company offers a dividend yield of 2.59%, providing income support for shareholders during the current period of price depreciation. Within the healthcare sector, UNH's valuation metrics suggest the market is pricing in near-term earnings uncertainty despite the company's dominant position in managed care and health services.
Smart Money Activity for UNH
UnitedHealth Group registers a composite smart money score of 54 out of 100, reflecting a neutral overall signal, per SID market data. Institutional positioning scores a perfect 25 out of 25, indicating maximum conviction among large fund managers who continue to maintain or build positions. Congressional trading activity scores 18.4 out of 25, suggesting notable interest from lawmakers with disclosed holdings. In contrast, insider sentiment scores 0.0 out of 25, and dark pool activity registers at 10.9 out of 25, pointing to muted signals from these channels. According to SEC Form 4 filings, there have been 20 insider transactions over the past 90 days, with 17 purchases compared to just 3 sales. This buy-to-sell ratio of nearly 6-to-1 represents a meaningfully bullish tilt from corporate insiders, who have increased personal stakes during the stock's recent decline. The divergence between the low insider score and the elevated purchase count warrants monitoring as it may reflect formulaic trading plan activity alongside discretionary buying.
UnitedHealth Group Earnings Outlook
UnitedHealth Group's most recent quarterly report delivered earnings per share of $6.38, surpassing the consensus estimate of $4.85 by $1.53, representing a 31.5% upside surprise, according to company earnings reports. The prior quarter also exceeded expectations, with actual EPS of $7.23 versus the $6.56 estimate, a positive surprise of $0.67. The quarter before that saw a marginal beat, with $2.11 actual versus $2.10 estimated. Looking ahead, analysts project EPS of $6.81 for the upcoming reporting period, per analyst estimates, with results expected on April 16, 2026. The pattern of consecutive earnings beats demonstrates management's ability to deliver above-consensus results, though the magnitude of beats has varied significantly from $0.01 to $1.53. The substantial Q1 beat suggests operational improvements or favorable medical cost trends that meaningfully outpaced Wall Street expectations during that period.
Wall Street Analyst Ratings for UNH
Wall Street consensus on UnitedHealth Group remains firmly bullish, with all five most recent analyst actions reiterating positive ratings, per Wall Street analyst reports. On July 21, 2026, Mizuho maintained its Outperform rating, while JP Morgan reiterated its Overweight stance on the same date. Barclays reaffirmed its Overweight rating on July 20, and both RBC Capital and UBS maintained Outperform and Buy ratings respectively on July 17, according to SID consensus data. Notably, none of the recent actions involved upgrades or downgrades, indicating stable conviction among major sell-side firms despite the stock's 8.54% decline over three months. The unanimous bullish positioning from five top-tier institutions suggests analysts view the current pullback as inconsistent with UNH's fundamental outlook. The clustering of reiterations around mid-July 2026, immediately following the company's earnings beat of $1.53 per share, reflects renewed confidence in the company's operational trajectory following strong quarterly results.
